Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBHNASDAQ:IBBNASDAQ:PPHNASDAQ:PSCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBHVanEck Biotech ETF$152.60+1.0%$155.23$135.34▼$183.64$349.45M0.858,317 shs7,499 shsIBBiShares Biotechnology ETF$126.58+1.5%$127.47$107.43▼$150.57$5.59B0.841.35 million shs1.14 million shsPPHVanEck Pharmaceutical ETF$89.46+0.8%$88.82$77.67▼$99.51$728.20M0.72214,889 shs213,588 shsPSCHInvesco S&P SmallCap Health Care ETF$41.26-0.4%$41.52$36.69▼$49.05$151.84M112,517 shs4,058 shs20 Stocks to Sell NowGet This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBHVanEck Biotech ETF+1.05%+3.18%-3.01%-7.54%-2.20%IBBiShares Biotechnology ETF+1.47%+3.75%-1.03%-8.85%-0.27%PPHVanEck Pharmaceutical ETF+0.75%+5.40%-1.83%-0.07%+2.17%PSCHInvesco S&P SmallCap Health Care ETF-0.70%+3.45%-4.67%-13.99%+0.63%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBHVanEck Biotech ETFN/AN/AN/AN/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AN/AN/APSCHInvesco S&P SmallCap Health Care ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBHVanEck Biotech ETF 2.67Moderate Buy$152.60N/AIBBiShares Biotechnology ETF 2.69Moderate Buy$126.58N/APPHVanEck Pharmaceutical ETF 2.67Moderate Buy$89.46N/APSCHInvesco S&P SmallCap Health Care ETF 2.73Moderate Buy$41.26N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBHVanEck Biotech ETFN/AN/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/APSCHInvesco S&P SmallCap Health Care ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBHVanEck Biotech ETFN/AN/A31.41∞N/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/A25.09∞N/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/A24.60∞N/AN/AN/AN/AN/APSCHInvesco S&P SmallCap Health Care ETFN/AN/A22.91∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBHVanEck Biotech ETF$1.250.82%N/AN/AN/AIBBiShares Biotechnology ETF$0.380.30%N/AN/AN/APPHVanEck Pharmaceutical ETF$1.701.90%N/AN/AN/APSCHInvesco S&P SmallCap Health Care ETF$0.090.22%N/AN/AN/ALatest IBB, PPH, BBH, and PSCH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/31/2025PPHVanEck Pharmaceutical ETFQuarterly$0.52452.36%4/1/20254/1/20254/4/20253/24/2025PSCHInvesco S&P SmallCap Health Care ETF$0.01423/24/20253/24/20253/28/20253/17/2025IBBiShares Biotechnology ETF$0.12123/18/20253/18/20253/21/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBHVanEck Biotech ETF32.05%IBBiShares Biotechnology ETF62.45%PPHVanEck Pharmaceutical ETFN/APSCHInvesco S&P SmallCap Health Care ETFN/AInsider OwnershipCompanyInsider OwnershipBBHVanEck Biotech ETFN/AIBBiShares Biotechnology ETFN/APPHVanEck Pharmaceutical ETFN/APSCHInvesco S&P SmallCap Health Care ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBHVanEck Biotech ETFN/A2.29 millionN/AOptionableIBBiShares Biotechnology ETFN/A44.15 millionN/AOptionablePPHVanEck Pharmaceutical ETF147,0008.14 millionN/AOptionablePSCHInvesco S&P SmallCap Health Care ETFN/A3.68 millionN/AOptionableIBB, PPH, BBH, and PSCH HeadlinesRecent News About These CompaniesStock Markets Analysis: Health Care Has Been a Top SectorFebruary 21, 2025 | fxempire.comInvesco Main Street Small Cap Fund Q4 2024 CommentaryFebruary 12, 2025 | seekingalpha.comShould You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?November 12, 2024 | zacks.comVHT Sep 2024 245.000 putSeptember 15, 2024 | au.finance.yahoo.comSmall-cap and mid-cap Health Care has room to rally - Roth MKMAugust 19, 2024 | msn.comInvesco Health Care Fund Q2 2024 ReviewAugust 14, 2024 | seekingalpha.comShould You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?July 30, 2024 | zacks.com5 Small-Cap ETFs Scaling New HighsJuly 29, 2024 | zacks.comShould You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?May 27, 2024 | zacks.comCI Global Asset Management launches the CI U.S. 500 Index ETFMay 23, 2024 | theglobeandmail.comBlockchain Adoption in Healthcare Could Spur These ETFsMay 22, 2024 | etftrends.comWhy Is Health Care Company Fortrea Stock Diving Today?May 13, 2024 | msn.comTop 5 Health Care Stocks That Could Sink Your Portfolio In Q2May 9, 2024 | msn.comInvesco Health Care S&P US Select Sector UCITS ETF (XLVP.L)May 9, 2024 | finance.yahoo.comOrganon Beats On Q1, Women's Health Leads the ChargeMay 2, 2024 | msn.comShould You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?March 26, 2024 | zacks.comVHT Apr 2024 285.000 callMarch 15, 2024 | finance.yahoo.comHealth Care Workers Underpin US Jobs Growth In FebruaryMarch 8, 2024 | msn.comVHT Mar 2024 245.000 putFebruary 19, 2024 | finance.yahoo.comVHT Jun 2024 265.000 putFebruary 18, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAre Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Signs of a more buyer-friendly housing market emerge for the spring homebuying seasonBy The Associated Press | April 6, 2025View Signs of a more buyer-friendly housing market emerge for the spring homebuying season5 Highest-Rated Dividend Stocks According to MarketBeatBy Thomas Hughes | April 10, 2025View 5 Highest-Rated Dividend Stocks According to MarketBeat3 Stocks With Explosive Sales Growth and Strong Cash FlowBy Leo Miller | April 14, 2025View 3 Stocks With Explosive Sales Growth and Strong Cash FlowIBB, PPH, BBH, and PSCH Company DescriptionsVanEck Biotech ETF NASDAQ:BBH$152.60 +1.58 (+1.05%) As of 04/30/2025 03:59 PM EasternThe BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.iShares Biotechnology ETF NASDAQ:IBB$126.58 +1.83 (+1.47%) As of 04/30/2025 04:00 PM EasterniShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.VanEck Pharmaceutical ETF NASDAQ:PPH$89.46 +0.67 (+0.75%) As of 04/30/2025 04:00 PM EasternThe VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.Invesco S&P SmallCap Health Care ETF NASDAQ:PSCH$41.26 -0.17 (-0.41%) As of 04/30/2025 02:40 PM EasternPowerShares S&P SmallCap Health Care Portfolio (the Fund) seeks investment results that correspond generally to the price and yield performance of the index called the S&P SmallCap 600 Capped HealthCare Index (the Underlying Index). The Underlying Index consists of common stocks of the United States healthcare companies. These are companies that are principally engaged in the business of providing healthcare-related products and services, including biotechnology, pharmaceuticals, medical technology and supplies, and facilities. The Fund seeks to normally invest at least 90% of its total assets in common stocks that comprise the Underlying Index. The Fund seeks to invest 25% or more of the value of its total assets in securities of issuers in an industry or group of industries to the extent that the Underlying Index concentrates in an industry or group of industries. The Fund's investment adviser is Invesco PowerShares Capital Management LLC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hims & Hers Stock Soars on Novo Nordisk Collaboration 3 Dividend Kings Outshining the Market in 2025 Tesla's Band-Aid Has Been Ripped Off: Rally Mode Engaged Amazon's Earnings Will Make or Break the Stock's Comeback Why D-Wave's Project With Davidson Is a Game-Changer For Quantum NXP Semiconductors: A Buy-and-Hold Stock in the Buy Zone Joby Aviation Shares Eye Breakout After Transition Flight Win Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
